The nocebo effect and its relevance for clinical practice

Psychosomatic Medicine

Volumn 73, Issue 7, 2011, Pages 598-603

  Colloca, Luana ^a   Miller, Franklin G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CLINICAL PRACTICE; CLINICAL RESEARCH; HUMAN; MEDICAL ETHICS; NOCEBO EFFECT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 80052484532     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3182294a50     Document Type: Review

References (59)

1. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008;59:195-206. (Pubitemid 352033692)
2. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007;147: 260-71. (Pubitemid 46907442)
3. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002;287:622-7. (Pubitemid 34252015)
4. Myers MG, Cairns JA, Singer J. The consent form as a possible cause of side effects. Clin Pharmacol Ther 1987;42:250-3. (Pubitemid 17155727)
5. Flaten MA, Simonsen T, Olsen H. Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 1999;61:250-5. (Pubitemid 29168656)
6. Lancman ME, Asconape JJ, Craven WJ, Howard G, Penry JK. Predictive value of induction of psychogenic seizures by suggestion. Ann Neurol 1994;35:359-61. (Pubitemid 24089662)
7. Luparello TJ, Leist N, Lourie CH, Sweet P. The interaction of psychologic stimuli and pharmacologic agents on airway reactivity in asthmatic subjects. Psychosom Med 1970;32:509-13.
8. Mondaini N, Gontero P, Giubilei G, Lombardi G, Cai T, Gavazzi A, Bartoletti R. Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med 2007;4:1708-12. (Pubitemid 47616863)
9. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol 2004;3: 679-84. (Pubitemid 39370638)
10. Miller FG, Kaptchuk TJ. The power of context: reconceptualizing the placebo effect. J R Soc Med 2008;101:222-5. (Pubitemid 351860052)
11. Lamont EB, Christakis NA. Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to". JAMA 2003; 290:98-104. (Pubitemid 37432871)
12. Sakala C. Letter from North America: understanding and minimizing nocebo effects in childbearing women. Birth 2007;34:348-50. (Pubitemid 350132648)
13. Grimes DA, Schulz KF. Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception 2011;83:5-9.
14. Kennedy WP. The nocebo reaction. Med World 1961;95:203-5.
15. Kissel P, Barrucand D. Placebos et effet placebo en medecine. Paris, France: Masson; 1964.
16. Ernst E, Resch KL. Concept of true and perceived placebo effects. BMJ 1995;311:551-3.
17. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med 2010;16:1277-83.
18. Colloca L, Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol 2007;20:435-9. (Pubitemid 47415134)
19. van Laarhoven AI, Vogelaar ML, Wilder-Smith OH, van Riel PL, van de Kerkhof PC, Kraaimaat FW, Evers AW. Induction of nocebo and placebo effects on itch and pain by verbal suggestions. Pain 2011;152:1486-94.
20. Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain 2008;136:211-8.
21. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. How the number of learning trials affects placebo and nocebo responses. Pain 2010;151: 430-9.
22. Mazzoni G, Foan L, Hyland ME, Kirsch I. The effects of observation and gender on psychogenic symptoms. Health Psychol 2010;29:181-5.
23. Schweiger A, Parducci A. Nocebo: the psychologic induction of pain. Pavlov J Biol Sci 1981;16:140-3. (Pubitemid 11023665)
24. Oftedal G, Straume A, Johnsson A, Stovner LJ. Mobile phone headache: a double blind, sham-controlled provocation study. Cephalalgia 2007;27: 447-55. (Pubitemid 46632604)
25. Stovner LJ, Oftedal G, Straume A, Johnsson A. Nocebo as headache trigger: evidence from a sham-controlled provocation study with RF fields. Acta Neurol Scand Suppl 2008;188:67-71. (Pubitemid 351595277)
26. Dworkin SF, Chen AC, LeResche L, Clark DW. Cognitive reversal of expected nitrous oxide analgesia for acute pain. Anesth Analg 1983;62: 1073-7. (Pubitemid 14202787)
27. Rodriguez-Raecke R, Doganci B, Breimhorst M, Stankewitz A, Buchel C, Birklein F, May A. Insular cortex activity is associated with effects of negative expectation on nociceptive long-term habituation. J Neurosci 30:11363-8.
28. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006; 26:12014-22. (Pubitemid 44772112)
29. Doganci B, Breimhorst M, Hondrich M, Rodriguez-Raecke R, May A, Birklein F. Expectations modulate long-term heat pain habituation. Eur J Pain 2011;15:384-8.
30. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, Tracey I. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011;3:70ra14.
31. Amanzio M, Corazzini LL, Vase L, Benedetti F. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain 2009;146:261-9.
32. Reuter U, Sanchez del Rio M, Carpay JA, Boes CJ, Silberstein SD. Placebo adverse events in headache trials: headache as an adverse event of placebo. Cephalalgia 2003;23:496-503. (Pubitemid 37114970)
33. Rief W, Nestoriuc Y, von Lilienfeld-Toal A, Dogan I, Schreiber F, Hofmann SG, Barsky AJ, Avorn J. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf 2009;32:1041-56.
34. Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Jablonsky G, Kostuk WJ, Melendez LJ, Myers MG, Sackett DL, Sealey BJ, Tanser PH. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985;313:1369-75. (Pubitemid 16211835)
35. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med 2006;166:155-60. (Pubitemid 43144937)
36. Cocco G. Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology 2009;112:174-7.
37. Silvestri A, Galetta P, Cerquetani E, Marazzi G, Patrizi R, Fini M, Rosano GM. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 2003;24:1928-32. (Pubitemid 37322702)
38. Varelmann D, Pancaro C, Cappiello EC, Camann WR. Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg 2010;110: 868-70.
39. Taddio A, Shah V, Gilbert-MacLeod C, Katz J. Conditioning and hyperalgesia in newborns exposed to repeated heel lances. JAMA 2002;288: 857-61.
40. Liccardi G, Senna G, Russo M, Bonadonna P, Crivellaro M, Dama A, D'Amato M, D'Amato G, Canonica GW, Passalacqua G. Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions. J Investig Allergol Clin Immunol 2004;14:104-7. (Pubitemid 38987680)
41. Lombardi C, Gargioni S, Canonica GW, Passalacqua G. The nocebo effect during oral challenge in subjects with adverse drug reactions. Eur Ann Allergy Clin Immunol 2008;40:138-41.
42. Colagiuri B, Zachariae R. Patient expectancy and post-chemotherapy nausea: a meta-analysis. Ann Behav Med 2010;40:3-14.
43. de la Cruz M, Hui D, Parsons HA, Bruera E. Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 2010;116:766-74.
44. Bovbjerg DH, Redd WH, Jacobsen PB, Manne SL, Taylor KL, Surbone A, Crown JP, Norton L, Gilewski TA, Hudis CA, Reichman BS, Kaufman RJ, Currie VE, Hakes TB. An experimental analysis of classically conditioned nausea during cancer chemotherapy. Psychosom Med 1992;54:623-37.
45. Roscoe JA, O'Neill M, Jean-Pierre P, Heckler CE, Kaptchuk TJ, Bushunow P, Shayne M, Huston A, Qazi R, Smith B. An exploratory study on the effects of an expectancy manipulation on chemotherapy-related nausea. J Pain Symptom Manage 2010;40:379-90.
46. Shelke AR, Roscoe JA, Morrow GR, Colman LK, Banerjee TK, Kirshner JJ. Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a University of Rochester Cancer Center community clinical oncology program study. J Pain Symptom Manage 2008;35:381-7. (Pubitemid 351410456)
47. Stockhorst U, Wiener JA, Klosterhalfen S, Klosterhalfen W, Aul C, Steingruber HJ. Effects of overshadowing on conditioned nausea in cancer patients: an experimental study. Physiol Behav 1998;64:743-53. (Pubitemid 28470593)
48. Katz J. The SilentWorld of Doctor and Patient. New York, NY: Free Press; 1984.
49. Berg JW, Appelbaum PS, Lidz CW, Parker LS. Informed Consent: Legal Theory and Clinical Practice. 2nd ed. New York, NY: Oxford University Press; 2001.
50. Miller FG, Colloca L. The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth 2011;32:229-43.
51. Edwards A, Elwyn G, Covey J, Matthews E, Pill R. Presenting risk informationVa review of the effects of "framing" and other manipulations on patient outcomes. J Health Commun 2001;6:61-82. (Pubitemid 33730948)
52. O'Connor AM, Pennie RA, Dales RE. Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization. J Clin Epidemiol 1996;49:1271-6. (Pubitemid 26386232)
53. Dworkin G. The Theory and Practice of Autonomy. Cambridge, UK: Cambridge University Press; 1988.
54. Egbert LD, Battit GE, Welch CE, Bartlett MK. Reduction of postoperative pain by encouragement and instruction of patients. A study of doctorpatient rapport. N Engl J Med 1964;270:825-7.
55. Gracely RH, Dubner R, Deeter WR, Wolskee PJ. Clinicians' expectations influence placebo analgesia. Lancet 1985;1:43. (Pubitemid 15160555)
56. Greenfield S, Kaplan S, Ware JE Jr. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med 1985;102:520-8. (Pubitemid 15109013)
57. Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physicianpatient interactions on the outcomes of chronic disease. Med Care 1989; 27(suppl 3):S110-27.
58. Brewin TB. Three ways of giving bad news. Lancet 1991;337:1207-9.
59. Petrie KJ, Muller JT, Schirmbeck F, Donkin L, Broadbent E, Ellis CJ, Gamble G, Rief W. Effect of providing information about normal test results on patients' reassurance: randomised controlled trial. BMJ 2007; 334:352